Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone

Dermatologic Surgery

Volumn 39, Issue 5, 2013, Pages 719-725

  Blixt, Elizabeth ^a   Nelsen, David ^b   Stratman, Erik ^b  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CASE STUDY; CLINICAL ARTICLE; ELECTRODESICCATION AND CURETTAGE; FEMALE; FOLLOW UP; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SCAR; SURGICAL TECHNIQUE;

AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CURETTAGE; DESICCATION; FACIAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84877764756     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/dsu.12122     Document Type: Article

References (30)

1. Harris RB, Griffith K, Moon TE,. Trends in the incidence of nonmelanoma skin cancers in southeastern arizona, 1985-1996. J Am Acad Dermatol 2001; 45: 528-36. (Pubitemid 32917246)
2. Ko CB, Walton S, Keczkes K, Bury HP, et al. The emerging epidemic of skin cancer. Br J Dermatol 1994; 130: 269-72. (Pubitemid 24204633)
3. Miller DL, Weinstock MA,. Nonmelanoma skin cancer in the united states: incidence. J Am Acad Dermatol 1994; 30: 774-8. (Pubitemid 24157120)
4. Rubin AI, Chen EH, Ratner D,. Basal-cell carcinoma. N Engl J Med 2005; 353: 2262-9. (Pubitemid 41697289)
5. Bath-Hextall F, Bong J, Perkins W, Williams H,. Interventions for basal cell carcinoma of the skin: systematic review. BMJ 2004; 329: 705.
6. Wong CS, Strange RC, Lear JT,. Basal cell carcinoma. BMJ 2003; 327: 794-8. (Pubitemid 37211176)
7. Lang P, Maize J, editors. Cancer of the skin. Elsevier: Philadelphia, PA, 2005.
8. Zak-Prelich M, Narbutt J, Sysa-Jedrzejowska A,. Environmental risk factors predisposing to the development of basal cell carcinoma. Dermatol Surg 2004; 30: 248-52. (Pubitemid 38313981)
9. Castori M, Morrone A, Kanitakis J, Grammatico P,. Genetic skin diseases predisposing to basal cell carcinoma. Eur J Dermatol 2012; 22: 299-309.
10. Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005; 294: 681-90. (Pubitemid 41159287)
11. Silverman MK, Kopf AW, Grin CM, Bart RS, et al. Recurrence rates of treated basal cell carcinomas. part 1: overview. J Dermatol Surg Oncol 1991; 17: 713-8.
12. Silverman MK, Kopf AW,. Recurrence rates of treated basal cell carcinomas [letter]. J Dermatol Surg Oncol 1993; 19: 76.
13. Rowe DE, Carroll RJ, Day CL Jr,. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315-28. (Pubitemid 19085793)
14. Marcil I, Stern RS,. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000; 136: 1524-30. (Pubitemid 32009273)
15. Marghoob A, Kopf AW, Bart RS, Sanfilippo L, et al. Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol 1993; 28: 22-8. (Pubitemid 23019559)
16. Robinson JK,. Risk of developing another basal cell carcinoma. A 5-year prospective study. Cancer 1987; 60: 118-20. (Pubitemid 17083562)
17. Telfer NR, Colver GB, Morton CA,. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48. (Pubitemid 351874512)
18. Goldman G,. The current status of curettage and electrodesiccation. Dermatol Clin 2002; 20: 569-78, ix. (Pubitemid 34840119)
19. Silverman MK, Kopf AW, Grin CM, Bart RS, et al. Recurrence rates of treated basal cell carcinomas. part 2: curettage-electrodesiccation. J Dermatol Surg Oncol 1991; 17: 720-6.
20. Silverman MK, Kopf AW, Grin CM, Bart RS, et al. Measuring lesion diameters [response to letter]. J Dermatol Surg Oncol 1992; 18: 249-53.
21. Kuijpers DI, Thissen MR, Neumann MH,. Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy. Am J Clin Dermatol 2002; 3: 247-59. (Pubitemid 34615388)
22. Greenlee RT,. Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA). Clin Med Res 2003; 1: 273-80.
23. Farasat S, Yu SS, Neel VA, Nehal KS, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011; 64: 1051-9.
24. Housman TS, Feldman SR, Williford PM, Fleischer AB Jr, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003; 48: 425-9. (Pubitemid 36337080)
25. Thissen MR, Neumann MH, Schouten LJ,. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999; 135: 1177-83. (Pubitemid 29493277)
26. Kopf AW, Bart RS, Schrager D, Lazar M, et al. Curettage- electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977; 113: 439-43. (Pubitemid 8071603)
27. Werlinger KD, Upton G, Moore AY,. Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodesiccation- curettage in a private dermatological practice. Dermatol Surg 2002; 28: 1138-42. (Pubitemid 36076392)
28. Knox JM, Freeman RG, Duncan WC, Heaton CL,. Treatment of skin cancer. South Med J 1967; 60: 241-6.
29. Chren MM, Torres JS, Stuart SE, Bertenthal D, et al. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Arch Dermatol 2011; 147: 540-6.
30. Institute of Medicine, Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. National Academy Press: Washington, DC, 2000.